Pre-clinical tests underway on medicines to combat cancer and tick borne encephalitis.
'During the analyses of the milk proteins we detected one that destroyed cancer cells and left the healthy ones alive.' Picture: The Siberian Times
The drug was created following studies on lactaptin, a human milk protein, said Academician Valentin Vlasov, of the Siberian Institute of Chemical Biology and Fundamental Medicine.
'Two medication are going through the pre-clinical trial now,' he said. 'During the analyses of the milk proteins we detected one very specific one, a tiny peptide that affected cancer cells. It destroyed cancer cells and left the healthy ones alive.'
On the base of this milk a genetic construction has been created with even stronger anti-cancer characteristics.
'Now what we have are cells produced by that protein,' he said.
Tests on mice showed the drug works specially well on types of cancer that produce metastasis to the liver and lungs
This is not the only anti-cancer drug the Institute - part of the Siberian Branch of the Russian Academy of Science - is working on, Vlasov said.
'We continue tests on anti tick born encephalitis.
'We have a protein, an antibody that deactivates the virus. This is almost a ready-to-go medication. It just needs to go through all the tests now.'
What I wasn't expecting was just how beautiful everything looked under the sparkling white blanket of snow.
The flame warms Siberia and even takes a dip in Lake Baikal en route to the Sochi Winter Games.
It should be called the 'Pacific region', he suggests.